Glucose-sensing in glucagon-like peptide-1-secreting cells

Diabetes. 2002 Sep;51(9):2757-63. doi: 10.2337/diabetes.51.9.2757.

Abstract

Glucagon-like peptide-1 (GLP-1) is released from intestinal L-cells in response to carbohydrate and fat in the diet. Despite the interest in GLP-1 as an antidiabetic agent, very little is known about the mechanism of stimulus-secretion coupling in L-cells. We investigated the electrophysiological events underlying glucose-induced GLP-1 release in the GLP-1-secreting cell line, GLUTag. Cells were studied using perforated-patch and standard whole-cell patch clamp recordings. GLUTag cells were largely quiescent and hyperpolarized in the absence of glucose. Increasing the glucose concentration between 0 and 20 mmol/l decreased the membrane conductance, caused membrane depolarization, and triggered the generation of action potentials. Action potentials were also triggered by tolbutamide (500 micro mol/l) and were suppressed by diazoxide (340 micro mol/l) or the metabolic inhibitor azide (3 mmol/l), suggesting an involvement of K(ATP) channels. Large tolbutamide-sensitive washout currents developed in standard whole-cell recordings, confirming the presence of K(ATP) channels. RT-PCR detected the K(ATP) channel subunits Kir6.2 and SUR1 and glucokinase. GLP-1 secretion was also stimulated by glucose over the concentration range 0-25 mmol/l and by tolbutamide. Our results suggest that glucose triggers GLP-1 release through closure of K(ATP) channels and action potential generation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Adenosine Triphosphate / physiology
  • Animals
  • Cell Line
  • Cell Membrane / physiology
  • Diazoxide / pharmacology
  • Electric Conductivity
  • Glucagon / metabolism*
  • Glucagon-Like Peptide 1
  • Glucokinase / metabolism
  • Glucose / metabolism*
  • Glucose / pharmacology
  • Glycosyltransferases
  • Hypoglycemic Agents / pharmacology
  • Membrane Proteins*
  • Peptide Fragments / metabolism*
  • Potassium Channels / drug effects
  • Potassium Channels / physiology
  • Potassium Channels, Inwardly Rectifying / metabolism
  • Protein Precursors / metabolism*
  • Repressor Proteins / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Saccharomyces cerevisiae Proteins*
  • Tolbutamide / pharmacology

Substances

  • Hypoglycemic Agents
  • Membrane Proteins
  • Peptide Fragments
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • Protein Precursors
  • Repressor Proteins
  • Saccharomyces cerevisiae Proteins
  • Glucagon-Like Peptide 1
  • Adenosine Triphosphate
  • Glucagon
  • Tolbutamide
  • Glycosyltransferases
  • SUR1 protein, S cerevisiae
  • Glucokinase
  • Glucose
  • Diazoxide